Careers – Bellicum Pharmaceuticals, Inc, jobs in pharmaceuticals.#Jobs #in #pharmaceuticals

Posted On May 5 2018 by

jobs in pharmaceuticals Smart weapons for the fight against cancer About Us Overview Management Team Board of Directors Clinical Advisory Board Careers Contact Us Product Candidates Pipeline BPX-501 BPX-601 BPX-701 CD19 Program Technology Overview CaspaCIDe GoCAR-T Scientific Literature Abstracts Presentations Clinical Trials BPX-501 in Blood Cancers Inherited Blood Disorders BPX-601 (GoCAR-T) and About Us Overview Management Team Board of Directors Clinical Advisory Board Careers Contact Us Product Candidates Pipeline BPX-501 BPX-601 BPX-701 CD19 Program Technology Overview CaspaCIDe GoCAR-T Scientific Literature Abstracts Presentations Clinical Trials BPX-501 in Blood Cancers Inherited Blood Disorders BPX-601 (GoCAR-T) and About Us Product Candidates Technology Clinical …


BIPI – LILLY, boehringer pharmaceuticals.#Boehringer #pharmaceuticals

Posted On May 5 2018 by

boehringer pharmaceuticals Welcome to the Boehringer Ingelheim Pharmaceuticals Inc.(BIPI) and Lilly USA, LLC (Lilly) Alliance on-line application and grant management portal. On January 11, 2011 BIPI and Lilly announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds. We are committed to supporting education that fosters innovative, high quality, independent medical education for healthcare professionals and patients that narrows unmet medical needs, maintains clinical excellence, and measurably improves health outcomes in areas of interest to the BIPI and Lilly Diabetes Alliance. By agreement between BIPI and Lilly, grant requests will be processed through the BIPI on-line …


BIPI – LILLY, boehringer pharmaceuticals.#Boehringer #pharmaceuticals

Posted On May 5 2018 by

boehringer pharmaceuticals Welcome to the Boehringer Ingelheim Pharmaceuticals Inc.(BIPI) and Lilly USA, LLC (Lilly) Alliance on-line application and grant management portal. On January 11, 2011 BIPI and Lilly announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds. We are committed to supporting education that fosters innovative, high quality, independent medical education for healthcare professionals and patients that narrows unmet medical needs, maintains clinical excellence, and measurably improves health outcomes in areas of interest to the BIPI and Lilly Diabetes Alliance. By agreement between BIPI and Lilly, grant requests will be processed through the BIPI on-line …


Laser Pharmaceuticals, Pharmaceutical Company, marketing pharmaceuticals.#Marketing #pharmaceuticals

Posted On May 3 2018 by

Welcome to Laser Pharmaceuticals Laser Pharmaceuticals, LLC is a privately held, specialty pharmaceutical company based in Alpharetta, GA focused on the sales, marketing and development of prescription products throughout the United States. Laser strives to provide pharmaceutical products of uncompromising quality, efficacy, and value to the industry. Building upon a rich 55 year history, Laser continues to grow in size, quality, and impact. Our Products Our pharmaceutical company has a reputable and well-prescribed portfolio of pharmaceutical products that have been trusted by Practitioners for over 50 years. With innovative allergy, cough cold and affordable, high quality generics to meet the …


Laser Pharmaceuticals, Pharmaceutical Company, marketing pharmaceuticals.#Marketing #pharmaceuticals

Posted On May 3 2018 by

Welcome to Laser Pharmaceuticals Laser Pharmaceuticals, LLC is a privately held, specialty pharmaceutical company based in Alpharetta, GA focused on the sales, marketing and development of prescription products throughout the United States. Laser strives to provide pharmaceutical products of uncompromising quality, efficacy, and value to the industry. Building upon a rich 55 year history, Laser continues to grow in size, quality, and impact. Our Products Our pharmaceutical company has a reputable and well-prescribed portfolio of pharmaceutical products that have been trusted by Practitioners for over 50 years. With innovative allergy, cough cold and affordable, high quality generics to meet the …


Nivagen Pharmaceuticals, marketing pharmaceuticals.#Marketing #pharmaceuticals

Posted On May 3 2018 by

Growth through Global Partnerships Product Development / Co-Development Model Nivagen’s business model is to identify and utilize the world`s best and economical CROs and CRAMs to develop and manufacture niche generic and OTC products. Acquisition and Licensing Model The US generic market is large and growing. The market is complex and fragmented and requires a variety of infrastructures to reach all major channels and segments. Partnerships Every business has its individual core strengths. One of Nivagen’s core strengths is the ability of our sales team to launch new generic products in the US market. Welcome to Nivagen Pharmaceuticals Nivagen is …


Cipher Pharmaceuticals Announces Beteflam Patch Accepted For Review By Health Canada, cipher pharmaceuticals.#Cipher #pharmaceuticals

Posted On Apr 23 2018 by

Cipher Pharmaceuticals Announces Beteflam Patch Accepted For Review By Health Canada MISSISSAUGA, ON , Feb. 12, 2015 /PRNewswire/ – Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) (“Cipher” or “the Company”) today announced that the Beteflam Patch (previously called the Betesil Patch) has been accepted for review by Health Canada. The Beteflam Patch is a novel, patent-protected, self-adhesive medicated plaster containing 0.1% betamethasone valerate, for the treatment of inflammatory skin conditions such as chronic plaque psoriasis (“CPP”). Topical corticosteroids remain the primary treatment for steroid-responsive inflammatory skin diseases, including mild to moderate CPP. Occlusion with plastic film dressings is a widely accepted …


Addex Therapeutics: about addex, addex pharmaceuticals.#Addex #pharmaceuticals

Posted On Apr 23 2018 by

addex pharmaceuticals allosteric modulators for human health Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. Addex lead drug candidate, dipraglurant (mGluR5 negative allosteric modulator or NAM) has successfully completed a Phase IIa POC in Parkinson’s disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter Phase III for PD-LID with support from the Michael J. Fox Foundation for Parkinson’s Research (MJFF). In parallel, dipraglurant’s therapeutic use in dystonia is being investigated with support from the Dystonia Medical Research Foundation (DMRF). Addex second clinical program, ADX71149 (mGluR2 positive …


Today s Stock Market News and Analysis, lotus pharmaceuticals.#Lotus #pharmaceuticals

Posted On Apr 23 2018 by

Today’s Stock Market News Analysis In my own former narrow way of thinking I conceived of entrepreneurship as strictly a money thing and not Read Full Story Latest News Browse News by Category Technology Commodities Investing ideas Market Intelligence Stay ahead of the markets with these must-read articles Stock Market Today Stocks to Watch Careful What You Wish For? Dow Gains 120 Points, Tech Bounces Back as Tax Reform Looms Featured Story from Latest Articles by Martin Tillier Martin Tiller’s new must-read column on the markets Enlightening. Entertaining. Every day. Only at NASDAQ.com. Edit Favorites Enter up to 25 symbols …


Unnati Pharmaceuticals Pvt, elder pharmaceuticals.#Elder #pharmaceuticals

Posted On Apr 23 2018 by

elder pharmaceuticals Call us: +91-22-6138 2222 | E-mail: [email protected] Iron Sucrose 5% Pyrogene Free Timolol Maleate Triclosan Ketoconazole Mirtazapine Baclofen Sodium Pico Sulphate Betacarotene 10% / 20% / 30% Nitazoxanide Lycopene Fluconazole Foundation Founder of our Organisation Late Shri Bhupatrai C Mehta had started a trading house with Four Principles derived from Four essentials of Life. Mr. Hetal Mehta, followed his principles and with the guidance of his elder brother Mr. Hemal Mehta. Expansion Now has come a long way of 20 years into pharmaceutical industry & transformed the company from a trading house to a Marketing Company serving as …